Dr Durga Bista

1. Acharya, A., Bista, D., Shrestha, B., Shrestha, S. and Shakya, R., 2026. Assessment of Anti-depressant-Induced Self-Reported Adverse Drug Reactions among Patients in a Tertiary Care Hospital in Nepal: A Cross-Sectional Study: A. Acharya et al. Drugs-Real World Outcomes, pp.1-12.
2. Bhatt RD, Shrestha A, Karmacharya BM, Timalsena D, Dhimal MN, Pradhan P, Bista D et al. Dietary Salt Intake in a Suburban Nepali Community: A Cross-Sectional Study Using 24-Hour Urinary Sodium. Kathmandu Univ Med J. 2025; 90 (2):209-15.
3. Bhusal, T., Bista, D. & Shrestha, R.K. Study on risk factors and associated drug related problems in patients with stroke. BMC Neurol 25, 117 (2025). https://doi.org/10.1186/s12883-025-04130-7
4. Joshi, A., Bista, D. & Shakya, R. Assessing level of awareness of atrial fibrillation among general public: a cross-sectional study. BMC Cardiovasc Disord 25, 265 (2025). https://doi.org/10.1186/s12872-025-04720-w
5. Adhikari, S., Bista, D., Shrestha, R. and Woods, D., 2024. Prescribing Patterns and Off-Label Use of Gabapentinoid Agents at Dhulikhel Hospital, Nepal: A Cross-Sectional Study. Journal of Pain Research, pp.4377-4391.
6. Khanal, Pooja, Durga Bista, and Rojeena Koju Shrestha. "Assessment of Knowledge and Medication Adherence Among Patients Prescribed with Oral Anticoagulants in Atrial Fibrillation at a Tertiary Care Centre: A Cross Sectional Study." Journal of Blood Medicine (2024): 533-547.
7. Rojeena Koju Shrestha; Durga Bista Rajani Shakya; Rajendra Koju; Ram Bahadur Gurung (October 2024). Prevalence of Atrial Fibrillation in Semiurban Nepal: Result From a Community Based Cross-Sectional Screening. Cardiology Research and Practice. DOI: 10.1155/2024/1759135.
8. Aashish Bhattarai; Rajani Shakya; Durga Bista (June 2024). Impact of Pharmacist-Led Intervention on Adherance to Inhalers, Inhalation Technique, and Disease Control among Asthma/COPD Patients in a Resource Limited Center: An Interventional Study. Patient Preference and Adherence. DOI: 10.2147/ppa.s460810
9. Binita Rupakheti, Badri KC, Durga Bista, Kashi Raj Pandey (July 2024). Treatment Adherence and Health-Related Quality of life Among Patients with Hypertension at Tertiary Healthcare Facility in Lalitpur, Nepal: A Cross-Sectional Study. Patient Preference and Adherence. 18:2077-2090. DOI: 10.2147/PPA.S47610
10. Ankita Ojha, Durga Bista, Badri KC (June, 2023) Patients’ Perceptions on Community Pharmacy Services of a Ward (10) of Kathmandu Metropolitan. Patient Preference and Adherence, 17:, 1487-1499, DOI: 10.2147/PPA.S395774.
11. Milan Phuyal, Uttam Budhathoki, Durga Bista et al. Xylanase-Producing Microbes and Their Real-World Application. International Journal of Chemical Engineering. Volume 2023 | Article ID 3593035 | https://doi.org/10.1155/2023/3593035
12. Madhu Giri, Rajani Shakya, Durga Bista et al. Medication Adherance in post myocardial infarction patients at Shahid Gangalal National Heart Center. Nepalese Heart Journal 2022; vol 19(1), 21-24.
13. Dikshya Giri, Durga Bista, Rajani Shakya et al. Study on occurrence of potential drug-drug interaction and associated factors in Hospitalised elderly pateints in the teaching hospital of Nepal. Journal of Karnali Education and Health Research (JKEHR), Vol 1 (1), 2022.
14. Shrestha, A., Maharjan, R., Karmacharya, B.M., Bajracharya, S., Jha, N., Shrestha, S., Aryal, A., Baral, P.P., Bhatt, R.D., Bhattarai, S. and Bista, D., 2021. Health system gaps in cardiovascular disease prevention and management in Nepal. BMC health services research, 21(1), pp.1-13.
15. Sapkota, S., Shrestha, S., Bista, D., Shrestha, A., Maharjan, R. and Bajracharya, S., 2021. Medical Products for Cardiovascular Disease Management in Nepal: a need assessment study. Kathmandu Univ Med J, pp.18-29.
16. Bista D, Chalmer L, Peterson GM, Bereznicki LR. Patient Characteristics and antithrombotic prescribing patterns in patient with atrial fibrillation in Tasmania. Clinical and Applied Thrombosis/Hemostasis. December 2015. https://www.ncbi.nlm.nih.gov/pubmed/26699867
17. Bista D, Chalmer L, Peterson GM, Bereznicki LR. Anticoagulant use in patients with non- valvular atrial fibrillation: has prescribing improve? Clinical and Applied Thrombosis/Hemostasis April 2016.https://www.ncbi.nlm.nih.gov/pubmed/27071408
18. Bista D, Chalmer L, Peterson GM, Bereznicki LR. Antithrombotic Usage Patterns and Outcomes among Elderly Patients Diagnosed with Atrial Fibrillation in Tasmania. Clinical and Applied Thrombosis/Hemostasis (under review).

Review articles
1. Durga Bista, Leanne Chalmers, Luke Bereznicki, Gregory Peterson. Potential use of NOACs in developing countries: pros and cons. European Journal of Clinical Pharmacology, 11 May 2014. http://www.ncbi.nlm.nih.gov/pubmed/24817486.
2. Durga Bista, Subish P, Shankar PR, Prabhu MM, Paudel R, Mishra P. Understanding the essentials of drug interactions - a potential need for safe and effective use of drugs. Kathmandu Univ Med J, 2007.
https://www.ncbi.nlm.nih.gov/pubmed/18604069
Conference presentations (Most recent only)
1. Maharjan T, Bista D, Shrestha RK. Prescription pattern and estimation of cost of illness of type-II diabetic patients in a tertiary care hospital Nepal. Boston, USA, May 7-10, 2023.
2. Arbindra Joshi, Durga Bista, Rajani Shakya. Assessing the level of awareness of atrial fibrillation among general public of Dhulikhel, Nepal. International Conference on pharmacy in Nepal. 405 November, 2022.
3. Rojeena K Shrestha, Durga Bista, Rajani Shakya. Monitoring standard of treatment in patients screened with atrial fibrillation. International Conference on pharmacy in Nepal. 4-5 November, 2022. 9th National summit of health and population scientist in Nepal. 11-12 April, 2023.
4. Aastha Rimal, Durga Bista, Rajani Shakya. Utilisation of DOACs in a cardiothoractic and vascular specialized hospital of Nepal. International Conference on pharmacy in Nepal. 4-5 November, 2022.
5. Preeti Niraula, Kusum Poudel, Binita Bhattrai, Durga Bista, Rajani Shakya. Prevalance of off-label use of drugs in pediatric pateints: a retrospective study. NHRC conference 2023. Kathmandu Nepal.
6. Durga Bista (Keynote Speaker). Screening for atrial fibrillation in community: Need of an hour. Fourth International Conference on Traditional Medicine. S.M.B.T Institute of Diploma Pharmacy. Nahsik, Maharastra, India, 6-7 Jan 2023.
7. Durga Bista, Gregory Peterson, Leanne Chalmers, Luke Bereznicki. Hospital readmission for major bleeding or thromboembolic complications in patients with atrial fibrillation. Australasian Pharmaceutical Sciences Association Conference. Hobart, Tasmania, 29 November - 2 December 2015.
8. Durga Bista, Gregory Peterson, Leanne Chalmers, Luke Bereznicki. Tasmanian Atrial Fibrillation Study: baseline characteristics. Australasian Pharmaceutical Sciences Association Conference. Dunedin, New Zealand, December 8-11, 2013.
9. Durga Bista, Gregory Peterson, Leanne Chalmers, Luke Bereznicki. Hospital readmission for bleeding or thromboembolic complications in patients newly diagnosed with atrial fibrillation. The 2nd European Stroke Organization Conference. 10-12 May 2016, Barcelona, Spain.